FIELD: medicine.
SUBSTANCE: treating prostate adenoma combined with chronic nonbacterial prostatitis is ensured by a drug therapy involving 5α-reductase inhibitor and α1-adrenergic blocking agent. The drug therapy is added with a prostate exposure to electromagnetic THz emission at nitric oxide frequencies 150.176-150.664 GHz and emission power density 0.2±0.05 mWt/cm2. The exposure duration is 30 minutes. The therapeutic course includes 10 daily procedures.
EFFECT: immediate pronounced anaesthetic effect, pronounced anti-inflammatory effect, improving urination and microcirculation parameters, reducing manifestations of fibrosclerotic changes in prostate tissues.
63 dwg, 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF VESICULAR PROSTATE COMPLEX DISEASE TREATMENT INVOLVING CRYOTHERAPY | 2007 |
|
RU2349291C1 |
| METHOD OF TREATING CHRONIC ABACTERIAL PROSTATITIS | 2012 |
|
RU2479331C1 |
| METHOD FOR COMPLEX TREATMENT OF CHRONIC BACTERIAL PROSTATITIS COMBINED WITH PROSTATE ADENOMA | 2019 |
|
RU2709681C1 |
| METHOD FOR INTERMITTENT THERAPY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA | 2013 |
|
RU2531944C1 |
| METHOD OF TREATING PATIENTS WITH CHRONIC NONBACTERIAL PROSTATITIS | 2015 |
|
RU2604715C2 |
| AGENT FOR PREVENTING AND TREATING PROSTATITIS AND PROSTATE ADENOMA | 2013 |
|
RU2538615C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF CHRONIC PROSTATITIS | 2019 |
|
RU2711657C1 |
| METHOD OF TREATING CHRONIC ABACTERIAL PROSTATITIS | 2012 |
|
RU2478408C1 |
| METHOD FOR DIAGNOSING CHRONIC VIRAL PROSTATITIS | 2023 |
|
RU2819516C1 |
| METHOD FOR DETERMINATION OF TREATMENT STRATEGY FOR LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA AGAINST THE BACKGROUND OF TESTOSTERONE DEFICIENCY | 2022 |
|
RU2795840C1 |
